Clinical Takeaway
A randomized controlled trial tested the Minder mobile app, co-developed with university students, to address mental health and substance use challenges during the college transition period. Digital tools like this are being studied because they offer scalable, accessible support for a population at elevated risk for emerging psychiatric and substance-related concerns.
#5 Effectiveness of the Minder Mobile Mental Health and Substance Use Intervention for University Students: Randomized Controlled Trial.
Citation: Vereschagin Melissa et al.. Effectiveness of the Minder Mobile Mental Health and Substance Use Intervention for University Students: Randomized Controlled Trial.. Journal of medical Internet research. 2024. PMID: 38536225.
Design: 5 Journal: 0 N: 3 Recency: 1 Pop: 2 Human: 1 Risk: 0
This randomized controlled trial provides evidence on the efficacy of a scalable digital intervention for addressing comorbid mental health and substance use disorders in a high-risk population during a critical developmental window. The study’s relevance lies in evaluating whether mobile-based interventions can effectively reduce symptom burden and substance use in university students, potentially informing broader implementation strategies for institutions seeking accessible, evidence-based prevention and treatment options. Since digital interventions offer significant advantages in reach and cost-effectiveness compared to traditional clinical services, demonstrating clinical effectiveness in this RCT could reshape how universities approach mental health and substance use screening and treatment delivery.
Abstract: BACKGROUND: University attendance represents a transition period for students that often coincides with the emergence of mental health and substance use challenges. Digital interventions have been identified as a promising means of supporting students due to their scalability, adaptability, and acceptability. Minder is a mental health and substance use mobile app that was codeveloped with university students. OBJECTIVE: This study aims to examine the effectiveness of the Minder mobile app in improving mental health and substance use outcomes in a general population of university students. METHODS: A 2-arm, parallel-assignment, single-blinded, 30-day randomized controlled trial was used to evaluate Minder using intention-to-treat analysis. In total, 1489 participants were recruited and randomly assigned to the intervention (n=743, 49.9%) or waitlist control (n=746, 50.1%) condition. The Minder app delivers evidence-based content through an automated chatbot and connects participants with services and university social groups. Participants are also assigned a trained peer coach to support them. The primary outcomes were measured through in-app self-assessments and included changes in general anxiety symptomology, depressive symptomology, and alcohol consumption risk measured using the 7-item General Anxiety Disorder scale, 9-item Patient Health Questionnaire, and US Alcohol Use Disorders Identification Test-Consumption Scale, respectively, from baseline to 30-day follow-up. Secondary outcomes included measures related to changes in the frequency of substance use (cannabis, alcohol, opioids, and nonmedical stimulants) and mental well-being. Generalized linear mixed-effects models were used to examine each outcome. RESULTS: In total, 79.3% (589/743) of participants in the intervention group and 83% (619/746) of participants in the control group completed the follow-up survey. The intervention group had significantly greater average reductions in anxiety symptoms measure
🧠 This randomized controlled trial evaluates a student-codeveloped mobile app for mental health and substance use support during the high-risk university transition period, addressing a genuine gap in accessible, scalable interventions for young adults. While the study’s strength lies in its participatory design and focus on a vulnerable population, clinicians should note that digital interventions often show efficacy disparities based on user engagement patterns, baseline severity, and socioeconomic factors that may not be fully captured in trial data. The abstract provided lacks detail on effect sizes, dropout rates, and whether benefits persisted beyond the study period, which are critical for assessing real-world durability and clinical meaningfulness. In clinical practice, the Minder app may serve as a useful adjunct for motivated students with mild to moderate symptoms seeking preventive or early intervention support, but should not replace traditional assessment and care for those with acute psychiatric illness or active substance use disorders requiring intensive treatment.